Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mingwei Zhou

Showing results (51-60 of 59) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 59 results.
Small (Weinheim an Der Bergstrasse, Germany)|July 28, 2025
Hybrid Printing Wrinkle-Free High-Resolution Circuits on Freeform Surfaces Via Adaptive Deformation of a Self-Supporting MeshZhenghao Li, Wenzheng Sun, Xiaoyang Zhu, et al.
Journal of Medicinal Chemistry|June 14, 2019
Discovery of Ziresovir as a Potent, Selective, and Orally Bioavailable Respiratory Syncytial Virus Fusion Protein InhibitorXiufang Zheng, Lu Gao, Lisha Wang, et al.
Nature Nanotechnology|May 27, 2020
Atomic reconstruction in twisted bilayers of transition metal dichalcogenidesAstrid Weston, Yichao Zou, Vladimir Enaldiev, et al.
Journal of Medicinal Chemistry|March 10, 2023
Discovery of Linvencorvir (RG7907), a Hepatitis B Virus Core Protein Allosteric Modulator, for the Treatment of Chronic HBV InfectionWeixing Zhang, Lei Guo, Haixia Liu, et al.
Journal of Medicinal Chemistry|June 13, 2020
Discovery of 3-Pyridyl Isoindolin-1-one Derivatives as Potent, Selective, and Orally Active Aldosterone Synthase (CYP11B2) InhibitorsYongfu Liu, Jun Wu, Mingwei Zhou, et al.
Journal of Medicinal Chemistry|August 14, 2020
Discovery of Pyrido[2,3-<i>b</i>]indole Derivatives with Gram-Negative Activity Targeting Both DNA Gyrase and Topoisomerase IVYimin Hu, Houguang Shi, Mingwei Zhou, et al.
Journal of Medicinal Chemistry|July 27, 2016
Design and Synthesis of Orally Bioavailable 4-Methyl Heteroaryldihydropyrimidine Based Hepatitis B Virus (HBV) Capsid InhibitorsZongxing Qiu, Xianfeng Lin, Mingwei Zhou, et al.
Journal of Medicinal Chemistry|October 16, 2012
Pharmacokinetic optimization of class-selective histone deacetylase inhibitors and identification of associated candidate predictive biomarkers of hepatocellular carcinoma tumor responseJason C Wong, Guozhi Tang, Xihan Wu, et al.
Journal of Medicinal Chemistry|March 25, 2017
Discovery and Pre-Clinical Characterization of Third-Generation 4-H Heteroaryldihydropyrimidine (HAP) Analogues as Hepatitis B Virus (HBV) Capsid InhibitorsZongxing Qiu, Xianfeng Lin, Weixing Zhang, et al.
Pageof 6

Showing results (51-60 of 59) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 59 results.
Small (Weinheim an Der Bergstrasse, Germany)|July 28, 2025
Hybrid Printing Wrinkle-Free High-Resolution Circuits on Freeform Surfaces Via Adaptive Deformation of a Self-Supporting MeshZhenghao Li, Wenzheng Sun, Xiaoyang Zhu, et al.
Journal of Medicinal Chemistry|June 14, 2019
Discovery of Ziresovir as a Potent, Selective, and Orally Bioavailable Respiratory Syncytial Virus Fusion Protein InhibitorXiufang Zheng, Lu Gao, Lisha Wang, et al.
Nature Nanotechnology|May 27, 2020
Atomic reconstruction in twisted bilayers of transition metal dichalcogenidesAstrid Weston, Yichao Zou, Vladimir Enaldiev, et al.
Journal of Medicinal Chemistry|March 10, 2023
Discovery of Linvencorvir (RG7907), a Hepatitis B Virus Core Protein Allosteric Modulator, for the Treatment of Chronic HBV InfectionWeixing Zhang, Lei Guo, Haixia Liu, et al.
Journal of Medicinal Chemistry|June 13, 2020
Discovery of 3-Pyridyl Isoindolin-1-one Derivatives as Potent, Selective, and Orally Active Aldosterone Synthase (CYP11B2) InhibitorsYongfu Liu, Jun Wu, Mingwei Zhou, et al.
Journal of Medicinal Chemistry|August 14, 2020
Discovery of Pyrido[2,3-<i>b</i>]indole Derivatives with Gram-Negative Activity Targeting Both DNA Gyrase and Topoisomerase IVYimin Hu, Houguang Shi, Mingwei Zhou, et al.
Journal of Medicinal Chemistry|July 27, 2016
Design and Synthesis of Orally Bioavailable 4-Methyl Heteroaryldihydropyrimidine Based Hepatitis B Virus (HBV) Capsid InhibitorsZongxing Qiu, Xianfeng Lin, Mingwei Zhou, et al.
Journal of Medicinal Chemistry|October 16, 2012
Pharmacokinetic optimization of class-selective histone deacetylase inhibitors and identification of associated candidate predictive biomarkers of hepatocellular carcinoma tumor responseJason C Wong, Guozhi Tang, Xihan Wu, et al.
Journal of Medicinal Chemistry|March 25, 2017
Discovery and Pre-Clinical Characterization of Third-Generation 4-H Heteroaryldihydropyrimidine (HAP) Analogues as Hepatitis B Virus (HBV) Capsid InhibitorsZongxing Qiu, Xianfeng Lin, Weixing Zhang, et al.
Pageof 6